Issue |
J Oral Med Oral Surg
Volume 26, Number 1, 2020
|
|
---|---|---|
Article Number | 9 | |
Number of page(s) | 5 | |
Section | Cas clinique et revue de la littérature / Up-to date review and case report | |
DOI | https://doi.org/10.1051/mbcb/2019034 | |
Published online | 03 February 2020 |
Up-to Date Review And Case Report
Ectopic teeth in a patient with Gorham-Stout disease previously treated by biphosphonates: a case report
1
Department of Cranio-Maxillo-Facial Surgery of the Pediatric Hospital, Hôpital Femme Mère Enfant, 59 Boulevard Pinel, 69677 Bron, France
2
Faculté d'Odontologie, Université Claude Bernard Lyon 1, Rue Guillaume Paradin, 69008 Lyon, France
* Correspondence: melanie.le-donne@hotmail.fr
Received:
16
April
2019
Accepted:
21
October
2019
Introduction: Gorham-Stout disease is a rare idiopathic condition of the bone that is characterized by a massive and spontaneous osteolysis, with a vascular or lymphatic proliferation in bone, which is then replaced by fibrous tissue. Observation: a 16-year-old patient was referred to the maxillofacial surgery department to remove ectopic teeth bilaterally in the ramus. He had Gorham-Stout disease, managed for many years in orthopedic surgery department for a lower limb lesion and in neurosurgery department for a breach of the meninges. He was treated for 4 years with bisphosphonates. The removal of the ectopic teeth went well, with a simple postoperative course. Discussion: Gorham-Stout disease physiopathology remains unknown. Facial bones are often involved, especially the mandible. There are many possible treatments, but, due to the rarity of the disease, no therapeutic consensus exists. Bisphosphonates seem to be a good way to control this condition. So far, no case of bisphosphonates related osteonecrosis of the jaw has been reported in children. Conclusion: Gorham-Stout disease can involve the mandible and may lead to ectopic teeth.
Key words: Gorham-Stout disease / ectopic teeth / rare disease / biphosphonates
© The authors, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.